Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERBB2 | P04626 | 17/20 | 0.75 |
| ▸ | EGFR | P00533 | 14/20 | 0.75 |
| ▸ | LCK | P06239 | 1/20 | 0.75 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.59 |
| ▸ | AURKA | O14965 | 1/20 | 0.58 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28768471 | 0.91 | ERBB2 (0.77) | ERBB2EGFRLCKKCNH2AURKA | |
| SCHEMBL2322666 | 0.91 | ERBB2 (0.77) | ERBB2EGFRLCKKCNH2AURKA | |
| SCHEMBL2250011 | 0.86 | EGFR (0.68) | ERBB2EGFRLCKKCNH2AURKA | |
| SCHEMBL2249176 | 0.84 | ERBB2 (0.79) | ERBB2EGFRLCKKCNH2AURKA | |
| SCHEMBL2251397 | 0.83 | ERBB2 (0.79) | ERBB2EGFRLCKKCNH2AURKA | |
| SCHEMBL2251452 | 0.83 | EGFR (0.70) | ERBB2EGFRLCKKCNH2AURKA | |
| SCHEMBL27718944 | 0.83 | EGFR (0.70) | ERBB2EGFRLCKKCNH2AURKA | |
| SCHEMBL19479997 | 0.82 | ERBB2 (0.77) | ERBB2EGFRLCKKCNH2AURKA | |
| SCHEMBL7236445 | 0.82 | EGFR (0.81) | ERBB2EGFRLCKAURKARPS6KB1 | |
| SCHEMBL2249350 | 0.81 | EGFR (0.64) | ERBB2EGFRLCKAURKARPS6KB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8003658-B2 | Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereof | HANMI HOLDINGS CO., LTD. (KR) | 2011-08-23 | — | — | US | disclosed |